Methadone and Buprenorphine treatment in United States jails and prisons: lessons from early adopters

To identify implementation barriers and facilitators to the adoption and implementation of programs that provide opioid agonist treatments (OAT) with methadone and buprenorphine to treat opioid use disorder in jails and prisons in the United States.